Correlation Between Merck and Cano Health
Can any of the company-specific risk be diversified away by investing in both Merck and Cano Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Cano Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Cano Health, you can compare the effects of market volatilities on Merck and Cano Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Cano Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Cano Health.
Diversification Opportunities for Merck and Cano Health
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Merck and Cano is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Cano Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cano Health and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Cano Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cano Health has no effect on the direction of Merck i.e., Merck and Cano Health go up and down completely randomly.
Pair Corralation between Merck and Cano Health
If you would invest 137.00 in Cano Health on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Cano Health or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Merck Company vs. Cano Health
Performance |
Timeline |
Merck Company |
Cano Health |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Merck and Cano Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and Cano Health
The main advantage of trading using opposite Merck and Cano Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Cano Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cano Health will offset losses from the drop in Cano Health's long position.Merck vs. Capricor Therapeutics | Merck vs. Soleno Therapeutics | Merck vs. Bio Path Holdings | Merck vs. Moleculin Biotech |
Cano Health vs. Oncology Institute | Cano Health vs. Lifestance Health Group | Cano Health vs. agilon health | Cano Health vs. Pennant Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |